
ICON Public Limited Company ICLR
€ 129.68
2.49%
Geschäftsbericht 2024
hinzugefügt 24.01.2026
Land |
|
IPO-Jahr |
1998 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
82.5 M |
Marktkapitalisierung |
$ 12.7 B |
EBITDA (LTM) |
$ 723 M |
P/E (LTM) |
44.87 |
P/S (LTM) |
2.32 |
EPS (LTM) |
3.44 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 22.91 | 5.19 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 31.15 | -5.73 % | $ 343 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.15 | - | $ 1.46 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 106.96 | 0.2 % | $ 4.22 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 32.18 | -1.74 % | $ 894 M | Nasdaq Global Market,SPB | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.24 | 3.95 % | $ 1.09 B | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 217.28 | 0.31 % | $ 159 B | NYSE,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 10.46 | 5.13 % | $ 297 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 70.02 | 0.07 % | $ 27 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.85 | 5.71 % | $ 8.12 M | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.32 | 0.13 % | $ 19.1 B | Nasdaq Capital Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 29.63 | 0.58 % | $ 20 B | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 22.93 | -2.18 % | $ 693 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 105.41 | 3.5 % | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Charles River Laboratories International
CRL
|
$ 186.37 | -1.5 % | $ 9.58 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 639.57 | -0.78 % | $ 52.7 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 117.03 | -2.25 % | $ 18.6 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 192.86 | 2.86 % | $ 35 B | NYSE,SPB | ||
|
Quidel Corporation
QDEL
|
$ 29.24 | 0.46 % | $ 1.23 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 190.6 | -0.06 % | $ 21.2 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 9.99 | -3.71 % | $ 1.3 B | Nasdaq Global Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 274.63 | -0.93 % | $ 23 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 65.25 | 0.55 % | $ 4.52 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 127.69 | -1.46 % | $ 38.8 B | NYSE,SPB | ||
|
Biomerica
BMRA
|
$ 2.26 | 0.44 % | $ 5.19 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 8.56 | 0.59 % | $ 536 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 534.04 | -1.47 % | $ 16.5 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 384.49 | 0.7 % | $ 28.5 B | NYSE,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.8 | -5.71 % | $ 2.04 M | Nasdaq Global Select Market |